| Pharmacokinetic-pharmacodynamic relationships of the anthracycline anticancer drugs R Danesi, S Fogli, A Gennari, P Conte, M Del Tacca Clinical pharmacokinetics 41, 431-444, 2002 | 281 | 2002 |
| The role of nitric oxide in anthracycline toxicity and prospects for pharmacologic prevention of cardiac damage S Fogli, P Nieri, M CRISTINA BRESCHI The FASEB Journal 18 (6), 664-675, 2004 | 192 | 2004 |
| Clinical pharmacology of intravitreal anti-VEGF drugs S Fogli, M Del Re, E Rofi, C Posarelli, M Figus, R Danesi Eye 32 (6), 1010-1020, 2018 | 178 | 2018 |
| Cytotoxic effects of Echinacea root hexanic extracts on human cancer cell lines A Chicca, B Adinolfi, E Martinotti, S Fogli, MC Breschi, F Pellati, ... Journal of ethnopharmacology 110 (1), 148-153, 2007 | 98 | 2007 |
| Pharmacogenetics of anticancer drug sensitivity in non-small cell lung cancer R Danesi, F De Braud, S Fogli, TM De Pas, A Di Paolo, G Curigliano, ... Pharmacological reviews 55 (1), 57-103, 2003 | 96 | 2003 |
| Anticancer activity of anandamide in human cutaneous melanoma cells B Adinolfi, A Romanini, A Vanni, E Martinotti, A Chicca, S Fogli, P Nieri European journal of pharmacology 718 (1-3), 154-159, 2013 | 94 | 2013 |
| Gemcitabine plus epirubicin plus taxol (GET) in advanced breast cancer: a phase II study PF Conte, A Gennari, S Donati, B Salvadori, E Baldini, C Bengala, ... Breast cancer research and treatment 68, 171-179, 2001 | 93 | 2001 |
| Inhibitory effect of suramin in rat models of angiogenesis in vitro and in vivo G Bocci, R Danesi, U Benelli, F Innocenti, A Di Paolo, S Fogli, ... Cancer chemotherapy and pharmacology 43, 205-212, 1999 | 93 | 1999 |
| Cytotoxic activity of oleocanthal isolated from virgin olive oil on human melanoma cells S Fogli, C Arena, S Carpi, B Polini, S Bertini, M Digiacomo, F Gado, ... Nutrition and cancer 68 (5), 873-877, 2016 | 91 | 2016 |
| An improved HPLC method for therapeutic drug monitoring of daunorubicin, idarubicin, doxorubicin, epirubicin, and their 13-dihydro metabolites in human plasma S Fogli, R Danesi, F Innocenti, A Di Paolo, G Bocci, C Barbara, ... Therapeutic drug monitoring 21 (3), 367, 1999 | 90 | 1999 |
| Understanding the Mechanisms of Resistance in EGFR-Positive NSCLC: From Tissue to Liquid Biopsy to Guide Treatment Strategy M Del Re, S Crucitta, G Gianfilippo, A Passaro, I Petrini, G Restante, ... International journal of molecular sciences 20 (16), 3951, 2019 | 79 | 2019 |
| Overexpression of TK1 and CDK9 in plasma-derived exosomes is associated with clinical resistance to CDK4/6 inhibitors in metastatic breast cancer patients M Del Re, I Bertolini, S Crucitta, L Fontanelli, E Rofi, C De Angelis, ... Breast Cancer Research and Treatment 178, 57-62, 2019 | 76 | 2019 |
| Oleocanthal and oleacein contribute to the in vitro therapeutic potential of extra virgin oil-derived extracts in non-melanoma skin cancer B Polini, M Digiacomo, S Carpi, S Bertini, F Gado, G Saccomanni, ... Toxicology in Vitro 52, 243-250, 2018 | 72 | 2018 |
| Pharmacogenetic determinants of anti-cancer drug activity and toxicity R Danesi, F De Braud, S Fogli, A Di Paolo, M Del Tacca Trends in Pharmacological Sciences 22 (8), 420-426, 2001 | 71 | 2001 |
| Gemcitabine, epirubicin and paclitaxel: pharmacokinetic and pharmacodynamic interactions in advanced breast cancer S Fogli, R Danesi, A Gennari, S Donati, PF Conte, M Del Tacca Annals of oncology 13 (6), 919-927, 2002 | 70 | 2002 |
| Pathophysiology and pharmacological targets of VEGF in diabetic macular edema S Fogli, S Mogavero, CG Egan, M Del Re, R Danesi Pharmacological research 103, 149-157, 2016 | 68 | 2016 |
| The role of drug-drug interactions in prostate cancer treatment: focus on abiraterone acetate/prednisone and enzalutamide M Del Re, S Fogli, L Derosa, F Massari, P De Souza, S Crucitta, ... Cancer treatment reviews 55, 71-82, 2017 | 67 | 2017 |
| Design, synthesis, and characterization of the antitumor activity of novel ceramide analogues M Macchia, S Barontini, S Bertini, V Di Bussolo, S Fogli, E Giovannetti, ... Journal of medicinal chemistry 44 (23), 3994-4000, 2001 | 66 | 2001 |
| Cannabinoid derivatives induce cell death in pancreatic MIA PaCa-2 cells via a receptor-independent mechanism S Fogli, P Nieri, A Chicca, B Adinolfi, V Mariotti, P Iacopetti, MC Breschi, ... FEBS letters 580 (7), 1733-1739, 2006 | 64 | 2006 |
| Identification of plasma microRNAs as new potential biomarkers with high diagnostic power in human cutaneous melanoma S Fogli, B Polini, S Carpi, B Pardini, A Naccarati, N Dubbini, M Lanza, ... Tumor Biology 39 (5), 1010428317701646, 2017 | 59 | 2017 |
